Log in or Sign up for Free to view tailored content for your specialty!
Pharmacology News
Birth control policies in pharmacies not enough to increase access, use
Expanding access to birth control through policies that allow pharmacies to prescribe them may not effectively address disparities in birth control use, according to research published in Health Affairs.
Neupro may reduce cognitive dysfunction among patients with Alzheimer’s disease
The dopaminergic agonist Neupro appeared to improve frontal cognitive functions and activities of daily living among patients with mild to moderate Alzheimer’s disease, according to study results published in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Telehealth feasible for migraine care
In this video, Christina L. Szperka, MD, MSCE, director of the Pediatric Headache Program and a pediatric neurologist at Children’s Hospital of Philadelphia, discusses migraine care and treatment strategies in the era of COVID-19.
Aimovig, Emgality show similar therapeutic benefit for headaches
Patients with migraine who switched from Aimovig to Emgality to treat their headaches reported similar improvements between the two treatments, according to research presented at the virtual American Headache Society Annual Meeting.
Hydroxychloroquine, azithromycin prescriptions skyrocket amid early days of COVID-19
Dispensed prescriptions of hydroxychloroquine in the U.S. increased 86.2%, while such prescriptions of chloroquine increased 158.6% from February to March 2020, data show.
Study: Adverse drug reactions common, many deemed preventable, in patients with CKD
A study conducted in France found adverse drug reactions were common in patients with chronic kidney disease, most notably due antithrombotic agents, but researchers suggested many of these reactions may be preventable.
Guest Commentary: Migraine treatment updates from American Headache Society meeting
A host of new migraine-specific therapies were reviewed during this year’s American Headache Society Annual Scientific Meeting. The treatments that are receiving the most attention are those that target calcitonin gene-related peptide.
Success of diabetes treatments varies by cardiovascular risk
Patients with diabetes and increased CVD risk who also received one of several diabetes treatments were more likely to have certain “favorable” health outcomes, researchers reported.
Survey: PCPs need greater hepatitis B vaccination awareness
Primary care physicians do not realize how low the rate of adult hepatitis B vaccination is in the United States, according to a small survey.
Patients with documented penicillin allergy more likely to receive ‘inferior’ antibiotics
Hospitalized patients who had a documented penicillin allergy had higher odds of receiving “inferior” antibiotics — some that could potentially cause adverse drug events, data published in JAMA Internal Medicine show.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read